GLYCATED HEMOGLOBIN (HbA1C)
ANVISA Registration Number: 81733730008TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDATRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECHRisk Class II
Device names
- Technical name
- GLYCATED HEMOGLOBIN (HbA1C)
- Risk class
- Class II
PT: HEMOGLOBINA GLICADA (HbA1C)
Registration details
- Registration Number
- 81733730008
- Process Number
- 25351188011201971
- CNPJ
- 15648426000204
Company information
- Registration Holder
- TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Jun 03, 2019
- Status
- Active
Official value: VIGENTE
About this record
Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81733730008 and manufactured by TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH. The registration is held by TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.